About
OTC
Areas of Focus
Categories
Generic DrugMidwest
Clinical Trials (49)
View allTotal Trials
49
As Lead Sponsor
49
As Collaborator
0
Total Enrollment
13,524
By Phase
PHASE3: 20PHASE4: 13PHASE2: 13PHASE1/PHASE2: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 48TERMINATED: 1
Clinical Trials Pipeline49 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05890001Lead Sponsor
A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease
PHASE3Completed
400 participants
Started: Apr 5, 2023 · Completed: Oct 8, 2024
NCT05587309Lead Sponsor
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis
PHASE3Completed
1,250 participants
Started: Oct 30, 2022 · Completed: Jun 16, 2025
NCT05587322Lead Sponsor
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
PHASE3Completed
800 participants
Started: Sep 6, 2022 · Completed: Apr 23, 2024
NCT04446299Lead Sponsor
Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
PHASE3Completed
519 participants
Started: Jul 13, 2020 · Completed: Jan 22, 2021
NCT04446312Lead Sponsor
Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
PHASE3Completed
500 participants
Started: Jul 13, 2020 · Completed: Feb 5, 2021
Locations (1)
Headquarters
Columbus, IN, United States
Map
Loading map...